Monash University is partnering with the University of Missouri and the University of Pennsylvania to develop first-in-class medicines designed to ...

Monash University is partnering with the University of Missouri and the University of Pennsylvania to develop first-in-class medicines designed to ...

Otsuka Pharmaceutical Development & Commercialization, Inc. and Otsuka Pharmaceutical Co., Ltd. (Otsuka) today announced new ...

Phase 1 dose-escalation advancing as planned, targeting SMARCA4 (BRG1)-mutant cancers with a focus on non-small cell lung ...

With an induced allosteric drug discovery platform, the company's core projects focus on the KRAS pathway and STING pathway. The company envisions becoming a global leader in research and development, ...

Healthtech and edtech are two of the fastest growing sectors, with the healthtech market size to reach $3.1 billion by 2033, while the global education technology market size is projected to reach ...

Reviewing the role, regulatory mechanisms and therapeutic potential of METTL16 in cancer Cancer remains a leading cause of mortality, with its onset ...

First Commercial Product Glecirasib Approved and Added to China's NRDL pan-KRAS and Innovative ADC Pipeline Continue to Advance BEIJING, SHANGHAI and BOSTON, March ...